Recent studies have demonstrated the efficacy of G‐CSF not only to reduce the risk of neutropenia but also to improve the survival of patients who underwent FOLFIRINOX treatment.30, 31. The gene discussed is CSF3; the disease is Decreased total neutrophil count.